Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services
Launched by MAKERERE UNIVERSITY · Jan 23, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Men who engage in sexual relations with other men (MSM)(1) are disproportionately affected by HIV and syphilis. Globally, gay men and other men who have sex with men have 28 times greater risk of HIV acquisition than adult men (15-49 years) in the general population.(2). Syphilis and HIV disproportionately affect MSM because of sexual network dynamics that include high-risk sexual practices and multiple sex partners.(3,4). HIV and syphilis co-infection is common because syphilis and HIV have similar modes of transmission(5,6). Having syphilis is associated with a 3-fold increased risk of HI...
Gender
MALE
Eligibility criteria
- • Inclusion Criteria:In both arms, peers will recruit network members who are
- • aged 18 years and older,
- • Self-report of anal sexual intercourse at least once in the prior quarter
- • self-identify as MSM,
- • not tested in the past three months or never tested for HIV or syphilis before;
- • willing to provide informed consent;
- • willing to undergo study procedures
- • Exclusion Criteria:We will exclude participants
- • Participants who already know that they have HIV and those who are on treatment for syphilis
- • Those enrolled in other HIV prevention trial
- • We shall exclude participants who don't speak English and Luganda
About Makerere University
Makerere University, located in Kampala, Uganda, is a leading institution of higher learning and research that plays a pivotal role in advancing health sciences and clinical research in Africa. With a strong commitment to improving public health outcomes, the university engages in a wide range of clinical trials and health-related studies, focusing on addressing pressing health challenges in the region. Makerere University collaborates with various local and international partners to enhance research capacity, promote innovative solutions, and contribute to evidence-based healthcare practices, ultimately aiming to improve the quality of life for communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wakiso, , Uganda
Patients applied
Trial Officials
Stephen Okoboi, BSc, MPH, PhD
Principal Investigator
Infectious Diseases Institute, Makerere University
Barbara A Castelnuovo, MD, MPH. PhD
Study Director
Infectious Diseases Institute, Makerere University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported